BD 3 Human

Beta Defensin-3 Human Recombinant
Cat. No.
BT13917
Source
Escherichia Coli.
Synonyms
HBD3, HBP3, DEFB3, HBD-3, HBP-3, DEFB103.
Appearance

Sterile Filtered lyophilized (freeze-dried) powder.

Purity
Greater than 95.0% as determined by(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Beta Defensin-3 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 45 amino acids and having a molecular mass of 5161.2 Dalton.
The BD-3 is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Defensins are a family of antimicrobial and cytotoxic peptides produced by neutrophils. These peptides share high sequence similarity. This gene encodes for beta-defensin 103A, a protein with broad-spectrum antimicrobial activity that plays a crucial role in the innate immune response of epithelial cells.
Description
Recombinant Human Beta-Defensin 3, expressed in E. coli, is a single, non-glycosylated polypeptide chain consisting of 45 amino acids with a molecular weight of 5161.2 Daltons. The purification process of BD-3 involves proprietary chromatographic methods.
Physical Appearance
Sterile Filtered Lyophilized (Freeze-dried) Powder
Formulation
The HBD-3 was lyophilized without the addition of any excipients.
Solubility
Reconstitute the lyophilized Beta Defensin-3 in sterile 18 megaohm-cm H2O to a concentration of at least 100 µg/ml. This solution can be further diluted in other aqueous solutions.
Stability
Lyophilized Beta Defensin-3 Recombinant remains stable at room temperature for 3 weeks. However, it is recommended to store it desiccated below -18°C. Upon reconstitution, BD-3 should be stored at 4°C for a period of 2-7 days. For long-term storage, store below -18°C. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 95.0% as determined by (a) Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) analysis and (b) Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) analysis.
Synonyms
HBD3, HBP3, DEFB3, HBD-3, HBP-3, DEFB103.
Source
Escherichia Coli.
Amino Acid Sequence
GIINTLQKYY CRVRGGRCAV LSCLPKEEQI GKCSTRGRKC CRRKK.

Product Science Overview

Structure and Characteristics

BD-3 is a 45-amino acid peptide with a molecular mass of approximately 5.2 kDa . It is characterized by its three intramolecular disulfide bonds, which distinguish it from alpha-defensins . The peptide is membrane-active and exhibits broad-spectrum antimicrobial activity against bacteria, viruses, and fungi .

Expression and Regulation

BD-3 is widely expressed in epithelial tissues, including the skin, respiratory tract, and gastrointestinal tract . It is produced by keratinocytes and airway epithelial cells and is upregulated in response to proinflammatory cytokines, microbial infections, and at the edges of skin wounds . This upregulation is part of the body’s natural defense mechanism to combat infections and promote healing.

Antimicrobial Activity

BD-3 exhibits strain-specific microbicidal activity and is effective against a broad range of pathogens, including Gram-positive and Gram-negative bacteria, as well as yeast . Its antimicrobial activity is measured by its ability to inhibit the growth of Escherichia coli, with an effective dose (ED50) ranging from 7.5 to 30 μg/mL .

Immunomodulatory Functions

In addition to its antimicrobial properties, BD-3 has several immunomodulatory functions. It can induce monocyte migration, activate mast cells, and increase vascular permeability . BD-3 also interacts with various receptors, including melanocortin receptors, cytokine receptors, and voltage-gated potassium channels . These interactions contribute to its role in inflammation and immune responses.

Recombinant Production

Recombinant human BD-3 is typically produced using Escherichia coli as the expression system . The recombinant protein is purified to a high degree of purity (>95%) and is available in both carrier-free and BSA-containing formulations . The carrier-free version is recommended for applications where the presence of BSA could interfere with experimental results .

Applications and Potential

BD-3 has promising applications in various fields, including medicine and biotechnology. Its broad-spectrum antimicrobial activity makes it a potential candidate for developing new antimicrobial therapies. Additionally, its immunomodulatory functions could be harnessed for treating inflammatory diseases and enhancing wound healing .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.